title: Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma.
abstract: Serum levels of lipid associated sialic acid (LASA), mucoid proteins (MP) and hexoses (galactose + mannose) were measured in 41 breast cancer patients, 14 patients with benign breast diseases and 36 healthy age matched female individuals. In breast carcinoma patients, we have observed significant increase in the levels of the three markers compared with the controls (P less than 0.001) and in MP and hexoses compared to the patients with benign breast diseases (P less than 0.001). LASA and hexoses levels were significantly higher in benign breast diseases with respect to controls (P less than 0.001 and P less than 0.01, respectively). We evaluated the sensitivity and specificity of the markers individually and in combination. MP were most sensitive (71.8%) and specific (71.4%). Both sensitivity and specificity were increased when combinations of the markers were studied. Combination of MP with LASA was most sensitive (97.4%) while the combination of MP and hexoses was most specific (92.9%). LASA was significantly elevated in infiltrating duct carcinoma compared to lobular carcinoma (P less than 0.001). MP and hexoses also showed higher mean value in infiltrating duct carcinoma than lobular carcinoma. The present study suggests that the combination of the markers investigated might be useful for diagnosis and classification of breast carcinoma.
authors.affiliation: Department of Cancer Biology, Gujarat Cancer and Research Institute, Asarwa, Ahmedabad, India.
authors.forename: P S
authors.initials: PS
authors.lastname: Patel
authors.forename: B R
authors.initials: BR
authors.lastname: Baxi
authors.forename: S G
authors.initials: SG
authors.lastname: Adhvaryu
authors.forename: D B
authors.initials: DB
authors.lastname: Balar
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood*; D001941:Breast Diseases / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D002277:Carcinoma / Q000097:blood; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D003937:Diagnosis, Differential; D006601:Hexoses / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D009088:Mucoproteins / Q000097:blood*; D019158:N-Acetylneuraminic Acid; D009367:Neoplasm Staging; D009961:Orosomucoid / Q000032:analysis; D012794:Sialic Acids / Q000097:blood*
chemical_list: D014408:Biomarkers, Tumor; D006601:Hexoses; D008055:Lipids; D009088:Mucoproteins; D009961:Orosomucoid; D012794:Sialic Acids; C054080:lipid-associated sialic acid; D019158:N-Acetylneuraminic Acid